Palisade Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.85

+0.04 (+2.21%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +137.8% upside

Low Target $2.36

Average Target $4.40

High Target $4.89

Current Price $1.85

Current
$1.85

Target
$4.40

$2.36 $4.40 avg $4.89

Scenario Analysis

Bear Case

$2.36

27.6%

Low target

Base Case

$4.40

+137.8%

Avg target

Bull Case

$4.89

+164.3%

High target

Risk/Reward

6.0x

Highly favorable

Price in Context

52-Week High

$2.86

-35.2% from high

52-Week Low

$0.53

+249.1% from low

Target vs 52W High

$4.40

+54.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+20.5%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.2%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+178.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.1%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-88.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-23.9%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.0%